From Yahoo Finance: 2025-05-22 08:52:00

Renaissance Investment Management released its Q1 2025 investor letter, noting a 4.3% loss in the S&P 500 due to tech stock valuations and US economic uncertainty. Despite this, Energy, Health Care, and Utilities sectors saw positive returns. Large-cap stocks outperformed smaller caps, with Value surpassing Growth in Q1. The strategy exceeded the Russell 1000 Growth benchmark but lagged the S&P 500.

In the same letter, AbbVie Inc. (NYSE: ABBV) was highlighted as a strong performer, gaining 0.79% in one month and 14.87% over 52 weeks. On May 21, 2025, ABBV stock closed at $181.80 per share with a market cap of $321.132 billion. Renaissance added ABBV to its portfolio, praising its stable business model and growth potential post-Humira patent expiration.

Despite ABBV’s strong performance, it is not among the 30 most popular stocks among hedge funds. 85 hedge fund portfolios held ABBV at the end of Q4, up from 68 in Q3. While ABBV shows promise, the focus is on AI stocks for higher returns in a shorter timeframe. Investors looking for AI opportunities can explore undervalued stocks with significant upside potential.



Read more at Yahoo Finance: AbbVie (ABBV) has a Stable and Highly Profitable Business Model